Winton Group LTD Catalent, Inc. Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$72.36 - $113.1 $382,639 - $598,072	5,288 Added 143.0%	8,986 $650,000
Q2 2022 Aug 10, 2022	BUY	$87.2 - $114.05 $322,465 - $421,756	3,698 New	3,698 $397,000
Q2 2018 Aug 20, 2018	SELL	$38.72 - $42.52 $3.31 Million - $3.63 Million	-85,378 Closed	0 $0
Q1 2018 May 21, 2018	SELL	$39.4 - $47.39 $306,847 - $369,073	-7,788 Reduced 8.36%	85,378 $0
Q4 2017 Feb 13, 2018	BUY	$37.27 - $43.02 $1.5 Million - $1.73 Million	40,115 Added 75.62%	93,166 $3.83 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $1.79 Million - $2.21 Million	53,051	53,051 $2.12 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.